publication date: Sep. 22, 2017

NCI outlines research priorities in annual plan and bypass budget for FY19

By Matthew Bin Han Ong

NCI has released its professional judgment budget proposal for the fiscal year 2019, requesting $6.38 billion—$1 billion more than FY17—to fully fund promising areas in cancer research.

The institute’s FY19 professional judgment budget proposal is a unique authority established by the National Cancer Act of 1971. The budget proposal is often referred to as the bypass budget, because it allows the director of NCI to communicate directly with the White House about budget priorities, rather than going through NIH or HHS.

Of the $1 billion—or 12 percent—increase requested in the bypass budget, NCI proposes a total increase of $591 million, which consists of a $301 million inflation adjustment and $290 million in additional funding for research in seven areas. The proposed budget also includes $400 million in funding for the Cancer Moonshot initiative.


“NCI supports research to better understand and identify cancer, research into cancer prevention (including the development of cancer vaccines), and research to identify and validate biomarkers in liquid biopsy biospecimens,” institute officials wrote in a statement Sept. 12 to The Cancer Letter. “NCI is committed to developing new therapies, such as immunotherapy, and new combinations of therapies … Continue reading NCI outlines research priorities in annual plan and bypass budget for FY19

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.